The mitochondrially-localized nucleoside diphosphate kinase D (NME4) is a novel metastasis suppressor

Marie-Lise Lacombe1, Frederic Lamarche2, Olivier De Wever3

  • 1Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France.

BMC Biology
|October 22, 2021
PubMed
Abstract

Insights

Mitochondrial protein NME4 (NDPK-D) suppresses cancer metastasis. Loss of NME4 function in mitochondria promotes cancer cell invasion and metastasis, highlighting mitochondria

Area of Science:

  • Mitochondrial Biology
  • Cancer Research
  • Metastasis Suppression

Background:

  • Mitochondrial nucleoside diphosphate kinase (NDPK-D, also known as NME4 or NM23-H4) is an enzyme primarily located in the mitochondrial intermembrane space.
  • Its role in cancer progression and metastasis has not been fully elucidated.

Purpose of the Study:

  • To investigate the function of NDPK-D (NME4) in cancer metastasis.
  • To determine the impact of mitochondrial alterations on metastatic potential.

Main Methods:

  • Construction of loss-of-function mutants for NDPK-D (NME4) affecting kinase activity or membrane interaction.
  • Expression of wild-type and mutant NDPK-D in cancer cells, alongside RNA interference-mediated depletion.
  • Assessment of cell migration, invasion, and metastasis in immunocompromised mouse models.

Main Results:

  • Loss-of-function mutations and depletion of NDPK-D (NME4) induced epithelial-mesenchymal transition, enhancing cell migration and invasion.
  • Mice injected with cells expressing mutant NDPK-D exhibited increased metastasis compared to those with wild-type.
  • Metastatic reprogramming involved mitochondrial fragmentation, a shift to glycolysis, increased ROS, and altered mitochondrial metabolism, promoting pro-metastatic signaling.

Conclusions:

  • NME4 functions as a novel metastasis suppressor gene, uniquely localized to mitochondria.
  • Mitochondria play a critical role in regulating metastatic dissemination.
  • NME4 expression correlates with reduced epithelial-mesenchymal transition markers and improved clinical outcomes in human cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.5K